TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3604886

Group type: EXPERIMENTAL
Intervention: Bipolar noncapturing conditioning stimuli (Sc) with pulse widths of 2 or 9 msec and strengths of twice diastolic threshold and 10 MA
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Unipolar cathodal noncapturing conditioning stimuli (Sc) with pulse widths of 2 or 9 msec and strengths of twice diastolic threshold and 10 MA
Number of subjects: 23

Group type: COMPARATOR
Intervention: Bipolar noncapturing conditioning stimuli (Sc) delivered 3 mm away from pacing stimuli
Number of subjects: 23

Group type: COMPARATOR
Intervention: Unipolar noncapturing conditioning stimuli (Sc) delivered 3 mm away from pacing stimuli
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Bipolar conditioning stimuli delivered during circus movement tachycardia
Number of subjects: 23
Study: 29718968

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (NaHCO3) supplementation (0.3 g·kg‐1 body weight)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (NaHCO3) supplementation during 10-week resistance training
Number of subjects: 8
Study: 28473520

Group type: EXPERIMENTAL
Intervention: Insertable menstrual cup
Number of subjects: 604

Group type: COMPARATOR
Intervention: Monthly sanitary pads
Number of subjects: 604

Group type: COMPARATOR
Intervention: Usual practice (controls)
Number of subjects: 604
Study: 25732222

Group type: EXPERIMENTAL
Intervention: 2 x 125 ml ONS (2.4 kcal/ml)/d for 12 weeks
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group with usual care
Number of subjects: 87
Study: 24269911

Group type: EXPERIMENTAL
Intervention: Join2move intervention (self-paced 9-week PA program)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 199
Study: 20978528

Group type: EXPERIMENTAL
Intervention: High-fat yogurt supplement
Number of subjects: 11

Group type: COMPARATOR
Intervention: Low-fat yogurt supplement
Number of subjects: 11
Study: 18718556

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12965979

Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy with ACE inhibitors
Number of subjects: 1860

Group type: COMPARATOR
Intervention: Antihypertensive therapy without ACE inhibitors
Number of subjects: 1860

Group type: EXPERIMENTAL
Intervention: Higher systolic blood pressure levels
Number of subjects: 1860

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure less than 110 mm Hg
Number of subjects: 1860
Study: 10220792

Group type: EXPERIMENTAL
Intervention: NSAID/ASA-induced erosions without Hp gastritis
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: NSAID/ASA-induced erosions with concomitant Hp gastritis
Number of subjects: 122

Group type: COMPARATOR
Intervention: Hp-induced erosions
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Histological diagnosis of NSAID/ASA-induced erosions
Number of subjects: 122
Study: 7604928

Group type: EXPERIMENTAL
Intervention: Early intervention (policy workbook and consultation via meetings and telephone calls)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Late intervention (no assistance or encouragement regarding tobacco use policies)
Number of subjects: 39
Study: 2223358

Group type: EXPERIMENTAL
Intervention: Isoflurane (12 patients)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Halothane (11 patients)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Prolonged administration of 1% isoflurane (5 patients)
Number of subjects: 23
Study: 27204

Group type: EXPERIMENTAL
Intervention: Chlorpheniramine (4 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Clemastine (1 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Promethazine (10 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Terfenadine (60 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31176540

Group type: EXPERIMENTAL
Intervention: PCV-13 (Prevenar-13)
Number of subjects: 0
Study: 28295923

Group type: EXPERIMENTAL
Intervention: Sofosbuvir plus ribavirin for 48 weeks
Number of subjects: 50
Study: 26418222

Group type: EXPERIMENTAL
Intervention: High Intensity Interval Training (HITR)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: High Intensity Continuous Training (HCTR)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Sedentary Control (SED)
Number of subjects: 34
Study: 22922554

Group type: EXPERIMENTAL
Intervention: Education/Exercise combined (EXE)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Education only (EDU)
Number of subjects: 23
Study: 21159081

Group type: EXPERIMENTAL
Intervention: Home-based management of malaria + Seasonal intermittent preventive treatment (IPTc) with AS+AQ
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Home-based management of malaria + Seasonal intermittent preventive treatment (IPTc) with AS+AQ (only children who received all three courses of IPTc)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Home-based management of malaria (HMM) alone
Number of subjects: 30
Study: 19809023

Group type: EXPERIMENTAL
Intervention: Bovine lactoferrin (BLF) 100 mg/d
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Bovine lactoferrin (BLF) 100 mg/d plus Lactobacillus rhamnosus GG (LGG) 6 x 10(9) colony-forming units/d
Number of subjects: 472

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 472
Study: 18174120

Group type: EXPERIMENTAL
Intervention: Postal plus optional Internet response arm
Number of subjects: 4213

Group type: COMPARATOR
Intervention: Usual postal survey arm
Number of subjects: 4213

Group type: EXPERIMENTAL
Intervention: Optional Internet response arm
Number of subjects: 4213

Group type: EXPERIMENTAL
Intervention: Overall preference
Number of subjects: 4213
Study: 15184627

Group type: EXPERIMENTAL
Intervention: rtPA and tirofiban (n = 13)
Number of subjects: 47

Group type: COMPARATOR
Intervention: rtPA only (n = 16)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Nontreated patients (n = 18)
Number of subjects: 47
Study: 11599908

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node dissection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine axillary node dissection
Number of subjects: 0
Study: 9503114

Group type: EXPERIMENTAL
Intervention: Cefazolin sodium prophylaxis
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (no prophylaxis)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Case patients (with SSI)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control patients (without SSI)
Number of subjects: 55
Study: 7845753

Group type: EXPERIMENTAL
Intervention: Intravenous ceftriaxone (65 mg/kg/day once daily, Group A, n = 25)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Oral cefixime (10 mg/kg/day divided every 12 hours, Group B, n = 25)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intravenous ceftriaxone (Group A)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Oral cefixime (Group B)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 50
Study: 3293973

Group type: EXPERIMENTAL
Intervention: Cefotaxime (CTX)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Netilmicin plus Penicillin (N + P)
Number of subjects: 236
Study: 30813584

Group type: EXPERIMENTAL
Intervention: 2 ounces of nuts
Number of subjects: 18

Group type: COMPARATOR
Intervention: 2 ounces of dairy
Number of subjects: 18
Study: 28580864

Group type: EXPERIMENTAL
Intervention: School policy changes in 16 schools, marketing campaign, increased social support and role modeling
Number of subjects: 904

Group type: COMPARATOR
Intervention: Control group (delayed-intervention condition)
Number of subjects: 904
Study: 26257323

Group type: EXPERIMENTAL
Intervention: Closed-loop therapy with standard prandial insulin boluses
Number of subjects: 8

Group type: COMPARATOR
Intervention: Closed-loop therapy with prandial boluses reduced by 25%
Number of subjects: 8
Study: 23914920

Group type: EXPERIMENTAL
Intervention: Innocent suspects during interrogation
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Innocent suspects who refused to confess
Number of subjects: 132

Group type: COMPARATOR
Intervention: Guilty suspects during interrogation
Number of subjects: 132
Study: 21859656

Group type: EXPERIMENTAL
Intervention: Soy drink (240 cc)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Cow's milk
Number of subjects: 23
Study: 19706088

Group type: EXPERIMENTAL
Intervention: 5% 5-fluorouracil cream applied once or twice daily under occlusion for 6 weeks
Number of subjects: 39
Study: 18257271

Group type: EXPERIMENTAL
Intervention: Migu tablet (MG)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: XLGB group
Number of subjects: 192

Group type: COMPARATOR
Intervention: Leli group
Number of subjects: 192

Group type: COMPARATOR
Intervention: Normal control group
Number of subjects: 192
Study: 15218812

Group type: EXPERIMENTAL
Intervention: Interferon beta‐1b 8 MIU given subcutaneously every other day for two years
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 11451784

Group type: EXPERIMENTAL
Intervention: Disclosure intervention (patients visited 2-3 times to disclose emotionally important events)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control (normal care from general practitioners)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Intervention (disclosure patients)
Number of subjects: 161
Study: 9487328

Group type: EXPERIMENTAL
Intervention: Intravenous nitroglycerin (NTG)
Number of subjects: 162
Study: 8110549

Group type: EXPERIMENTAL
Intervention: Cricoid pressure group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 2470310

Group type: EXPERIMENTAL
Intervention: Cisplatin, 80 mg/m2 alone (CDDP regimen)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Combination chemotherapy (MOB-P: vincristine 1 mg, methotrexate 10 mg/m2 d 1, 2, 3, bleomycin 10 mg/m2 d 1, 2, 3)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Cisplatin alone (CDDP regimen)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Combination chemotherapy (MOB-P)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Among responders
Number of subjects: 241
Study: 31605797

Group type: EXPERIMENTAL
Intervention: Pemetrexed + Gefitinib (P+G)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Gefitinib
Number of subjects: 191
Study: 29844250

Group type: EXPERIMENTAL
Intervention: Flavonoids (Fs)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Centella asiatica (Ca)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Traditional treatment (Control Group C)
Number of subjects: 98
Study: 28802634

Group type: EXPERIMENTAL
Intervention: Heparin administration in RS group
Number of subjects: 24

Group type: COMPARATOR
Intervention: Heparin administration in NS group
Number of subjects: 24
Study: 26263381

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (AET)
Number of subjects: 39
Study: 24062371

Group type: EXPERIMENTAL
Intervention: PEDS‐ES (PEDS Early Screener)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: PEDS‐ES without additional risk factors
Number of subjects: 87
Study: 20403476

Group type: EXPERIMENTAL
Intervention: Primary Percutaneous Coronary Intervention (PCI)
Number of subjects: 1190
Study: 18559232

Group type: EXPERIMENTAL
Intervention: Red peony root decoction
Number of subjects: 96

Group type: COMPARATOR
Intervention: Rhubarb
Number of subjects: 96
Study: 16951825

Group type: EXPERIMENTAL
Intervention: Reperfusion (WR)
Number of subjects: 154

Group type: COMPARATOR
Intervention: No Reperfusion (WtR)
Number of subjects: 154
Study: 12716399

Group type: EXPERIMENTAL
Intervention: Nurse-health advocate home visiting program
Number of subjects: 0
Study: 11126939

Group type: EXPERIMENTAL
Intervention: Naming
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Semantic categorization
Number of subjects: 0
Study: 9349079

Group type: EXPERIMENTAL
Intervention: Prophylactic intravenous ephedrine 0.25 mg.kg‐1
Number of subjects: 46

Group type: COMPARATOR
Intervention: Intravenous fluid preloading with Hartmann's solution 20 ml.kg‐1
Number of subjects: 46
Study: 8223792

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (50 micrograms bd)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Placebo (current therapy)
Number of subjects: 258
Study: 3707815

Group type: EXPERIMENTAL
Intervention: Acyclovir tablets (2 X 200 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Intraduodenal infusion of acyclovir (400 mg in 500 ml of 5% dextrose solution over 4 h)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Sipping acyclovir solution (same as infusion, sipped at 10.4 ml every 5 min for 4 h)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Intraduodenal infusion of acyclovir (400 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Sipping acyclovir solution
Number of subjects: 9
Study: 29762363

Group type: EXPERIMENTAL
Intervention: DTaP-IPV-HB-PRP-T vaccine (group 1)
Number of subjects: 529

Group type: COMPARATOR
Intervention: Reconstituted DTaP-HB-IPV/PRP-T comparator (group 2)
Number of subjects: 529
Study: 26980210

Group type: EXPERIMENTAL
Intervention: Plasma betaine
Number of subjects: 3621

Group type: EXPERIMENTAL
Intervention: Urine betaine
Number of subjects: 3621

Group type: EXPERIMENTAL
Intervention: Dimethylglycine
Number of subjects: 3621

Group type: EXPERIMENTAL
Intervention: Sarcosine
Number of subjects: 3621

Group type: EXPERIMENTAL
Intervention: Urine sarcosine
Number of subjects: 3621
Study: 23868810

Group type: EXPERIMENTAL
Intervention: Tropisetron 2 mg
Number of subjects: 296

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 296
Study: 22770758

Group type: EXPERIMENTAL
Intervention: High thoracic epidural analgesia (HTEA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: General anesthesia without HTEA (Control)
Number of subjects: 60
Study: 20798075

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 0
Study: 17662090

Group type: EXPERIMENTAL
Intervention: L-Citrulline (3 g bid)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: L-Citrulline
Number of subjects: 20
Study: 16380708

Group type: EXPERIMENTAL
Intervention: Sibutramine (10 mg daily for 6 months)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low caloric diet
Number of subjects: 60
Study: 12747281

Group type: EXPERIMENTAL
Intervention: Rofecoxib 500 mg
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 10758047

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter-defibrillator (ICD)
Number of subjects: 659

Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 659
Study: 8821514

Group type: EXPERIMENTAL
Intervention: Nifedipine extended release capsule (Aprical retard)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard retard tablet
Number of subjects: 24
Study: 1483293

Group type: EXPERIMENTAL
Intervention: Oral glucose (75 g) + pyridostigmine (120 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo + pyridostigmine (120 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Oral glucose (75 g)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Pyridostigmine (120 mg) alone
Number of subjects: 8
Study: 2990708

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy (cyclophosphamide, vincristine, semustine)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Standard-dose chemotherapy (cyclophosphamide, vincristine, semustine)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy (cyclophosphamide, vincristine, semustine) in patients with extensive disease
Number of subjects: 28

Group type: COMPARATOR
Intervention: Standard-dose chemotherapy (cyclophosphamide, vincristine, semustine) in patients with extensive disease
Number of subjects: 28
Study: 29945245

Group type: EXPERIMENTAL
Intervention: Neural Tension Technique (NTT)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sham technique
Number of subjects: 54
Study: 29782217

Group type: EXPERIMENTAL
Intervention: Dupilumab 200 mg every 2 weeks
Number of subjects: 1902

Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 2 weeks
Number of subjects: 1902

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 1902

Group type: EXPERIMENTAL
Intervention: Dupilumab 200 mg every 2 weeks in patients with eosinophil count ≥300/mm³
Number of subjects: 1902

Group type: COMPARATOR
Intervention: Matched placebo in patients with eosinophil count ≥300/mm³
Number of subjects: 1902

Group type: EXPERIMENTAL
Intervention: Dupilumab
Number of subjects: 1902
Study: 26556577

Group type: EXPERIMENTAL
Intervention: EMD
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: βTCP/HA
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: EMD + βTCP/HA
Number of subjects: 41

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 41
Study: 24878827

Group type: EXPERIMENTAL
Intervention: Yoga (90 minutes/day for 15 days)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Walking (90 minutes/day for 15 days)
Number of subjects: 68
Study: 22412837

Group type: EXPERIMENTAL
Intervention: Pioglitazone (30 mg/day for 14 days)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Prednisone (40 mg/day for 4 days)
Number of subjects: 39
Study: 20113919

Group type: EXPERIMENTAL
Intervention: Athletes (17.69 hours/week)
Number of subjects: 434

Group type: COMPARATOR
Intervention: Controls (4.69 hours/week)
Number of subjects: 434
Study: 18018838

Group type: EXPERIMENTAL
Intervention: Noninvasive mechanical ventilation
Number of subjects: 129

Group type: COMPARATOR
Intervention: Invasive mechanical ventilation
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: APACHE II <= 20
Number of subjects: 129

Group type: COMPARATOR
Intervention: APACHE II > 20
Number of subjects: 129
Study: 16153510

Group type: EXPERIMENTAL
Intervention: Patients with LV restrictive pattern (n=56)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Patients with pseudonormalization pattern (n=36)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Patients with abnormal relaxation pattern (n=34)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Patients with ejection fraction of 35% or less (pseudonormal group)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control group (patients with ejection fraction of 35% or more)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Overall comparison of patients with decreased LV systolic function to age-matched control subjects
Number of subjects: 126
Study: 12647845

Group type: EXPERIMENTAL
Intervention: Injection of insulin lispro before the afternoon meal
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (no injection)
Number of subjects: 43
Study: 9709768

Group type: EXPERIMENTAL
Intervention: Intraoperative corneal cauterization (group A)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (no cauterization, group B)
Number of subjects: 29
Study: 7972810

Group type: EXPERIMENTAL
Intervention: Integrated endorectal PPA coils
Number of subjects: 71

Group type: COMPARATOR
Intervention: Pelvic phased-array (PPA) coils
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Consensus image interpretation
Number of subjects: 71

Group type: COMPARATOR
Intervention: Single-reader image interpretation
Number of subjects: 71
Study: 2438799

Group type: EXPERIMENTAL
Intervention: Org 10172 (1600 anti-Xa units b.d.)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Org 10172 (2400 anti-Xa units b.d.)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Org 10172 (800 anti-Xa units b.d.)
Number of subjects: 60
Study: 31937653

Group type: EXPERIMENTAL
Intervention: tDCS-TAU
Number of subjects: 214

Group type: COMPARATOR
Intervention: TAU alone
Number of subjects: 214
Study: 30170456

Group type: EXPERIMENTAL
Intervention: Off-pump technique
Number of subjects: 94

Group type: COMPARATOR
Intervention: On-pump technique
Number of subjects: 94
Study: 26547499

Group type: EXPERIMENTAL
Intervention: Ledipasvir/Sofosbuvir (once-daily dosage)
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Ledipasvir/Sofosbuvir with ribavirin
Number of subjects: 308

Group type: COMPARATOR
Intervention: Ledipasvir/Sofosbuvir
Number of subjects: 308
Study: 24556911

Group type: EXPERIMENTAL
Intervention: Intravenous L‐alanyl‐L‐glutamine dipeptide supplementation (0.5 g/kg body weight/day) for 5 days
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Low glutamine levels at day 6
Number of subjects: 142
Study: 23735512

Group type: EXPERIMENTAL
Intervention: Subendocardial viability ratio (SEVR) in living patients
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Subendocardial viability ratio (SEVR) in deceased patients
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Reduction of SEVR values during the study (third tertile)
Number of subjects: 212
Study: 21778673

Group type: EXPERIMENTAL
Intervention: Menatetrenone (45 mg daily) and risedronate sodium (once weekly)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Placebo and risedronate sodium (once weekly)
Number of subjects: 231
Study: 19318702

Group type: EXPERIMENTAL
Intervention: Consumption of a light diet during labour
Number of subjects: 2426

Group type: COMPARATOR
Intervention: Water during labour
Number of subjects: 2426
Study: 16400468

Group type: EXPERIMENTAL
Intervention: Gabexate (300 mg continuous intravenous infusion in 500 mL Ringer's solution at 111 mL/h for 4.5 hours)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Placebo (Ringer's solution)
Number of subjects: 193
Study: 15301655

Group type: COMPARATOR
Intervention: no‐incentive vouchers
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: incentive vouchers alone
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: incentive vouchers plus relationship counseling
Number of subjects: 125
Study: 11268223

Group type: COMPARATOR
Intervention: Garlic preparations
Number of subjects: 1798
Study: 9262695

Group type: EXPERIMENTAL
Intervention: Selective IVP group (19 IVPs performed)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Routine IVP group (40 patients)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Selective IVP group
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 81
Study: 8335855

Group type: EXPERIMENTAL
Intervention: Heated moisturized air (delivered at 40 L/min and 43 degrees C)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Room temperature moisturized air
Number of subjects: 0
Study: 6387282

Group type: EXPERIMENTAL
Intervention: Diethyl ether extraction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ethanol-acetone extraction
Number of subjects: 0
Study: 31190822

Group type: EXPERIMENTAL
Intervention: 20-Hz rTMS treatment for 4 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 60